CompuMed, Inc., a leader in providing diagnostic telemedicine has amended its certificate of incorporation to reduce the number of authorized shares from Twenty Million to Five Million.
LOS ANGELES, CA / ACCESSWIRE / May 25, 2023 / CompuMed, Inc. (OTC PINK:CMPD), a leader in providing diagnostic telemedicine has amended its certificate of incorporation to reduce the number of authorized shares from Twenty Million (20,000,000) to Five Million (5,000,000). The corporation made this change to save on annual franchise fees charged by Delaware, its state of incorporation. The amendment was approved by the board of directors and the corporation obtained written consents from stockholders holding in excess of half of the 1,678,707 shares of common stock currently outstanding to effectuate the reduction in the number of shares authorized for issuance.
Inquiries regarding this can be sent to investorrelations@compumedinc.com or call 310-258-5002.
About CompuMed, Inc.
CompuMed, Inc. (OTCPink: CMPD) Diagnostic Telemedicine services provide patients with the highest level of clinical care at reduced costs. Its telecardiology and teleradiology offerings provide real-time access to U.S. Board-Certified specialists through cloud-based technology and integrated medical devices to medical facilities anywhere in the world. The Corporation has been in business for over 26 years and services over 1,000 clinical settings. CompuMed is headquartered in Los Angeles, CA. Visit CompuMed at www.compumedinc.com.
Forward-Looking Statements
Certain statements in this press release are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all passages containing words such as “will,” “aims,” “anticipates,” “becoming,” “believes,” “continue,” “estimates,” “expects,” “future,” “intends,” “plans,” “predicts,” “projects,” “targets,” or “upcoming.” Forward-looking statements also include any other passages that are primarily relevant to expected future events or that can only be evaluated by events that will occur in the future. Forward-looking statements are based on the opinions and estimates of management at the time the statements are made and are subject to certain risks and uncertainties that could cause actual results to differ materially from those anticipated or implied in the forward-looking statements. Factors that could cause actual results to vary from current expectations and forward-looking statements contained in this press release include, but are not limited to: the timing and volume of business activity from our clients and our ability to continue to provide products and services to such clients; the loss of, or reduction of business from, material clients; our liquidity and cash position; changes in technology; our ability to protect the Corporation’s net operating losses and tax benefits; volatility and changes in our stock price, corporate or other market conditions; changes in government regulations or economic conditions; the impact of increased competition and pricing; capacity and supply chain constraints or difficulties; and other factors contained in the Corporation’s filings posted on the OTC Markets website. All such forward-looking statements are expressly qualified by these cautionary statements. The Corporation expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect events, conditions or circumstances on which any such statement is based after the date hereof, except as required by law.
SOURCE: CompuMed, Inc.
View source version on accesswire.com:
https://www.accesswire.com/757420/CompuMed-Announces-Approval-and-Amendment-to-Reduce-Authorized-Shares
